Page last updated: 2024-08-17

cycloserine and Smoking Cessation

cycloserine has been researched along with Smoking Cessation in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Alavi, N; Baird, SO; Dutcher, CD; Kauffman, BY; Lee-Furman, E; Otto, MW; Papini, S; Piper, ME; Rosenfield, B; Rosenfield, D; Smits, JAJ; Zvolensky, MJ1
Cather, C; Evins, AE; Hearon, BA; Hoeppner, SS; Laffer, AB; Moshier, SJ; Otto, MW; Pachas, GN; Smits, JAJ; Ward, HB1
Kauffman, BY; Lee-Furman, E; Otto, MW; Piper, ME; Powers, MB; Rosenfield, D; Smits, JA; Zvolensky, MJ1
Levin, ED; Petro, A; Rose, JE; Slade, S; Wells, C1
Curran, HV; Das, RK; Gibson, AJ; Joye, A; Kamboj, SK; Morgan, CJ1
Aziziyeh, AI; Bordnick, PS; Culbertson, C; Fintzy, RE; Haile, CN; Hawkins, RY; La Garza, R; LaBounty, KR; Mahoney, JJ; Newton, TF; Ross, EL; Yoon, JH1

Trials

5 trial(s) available for cycloserine and Smoking Cessation

ArticleYear
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
    Drug and alcohol dependence, 2020, 03-01, Volume: 208

    Topics: Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Pilot Projects; Smokers; Smoking; Smoking Cessation; Smoking Reduction; Treatment Outcome; Young Adult

2020
A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
    Cognitive behaviour therapy, 2019, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Craving; Cues; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Middle Aged; Self Report; Smoking; Smoking Cessation; Treatment Outcome; Young Adult

2019
Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
    Contemporary clinical trials, 2016, Volume: 48

    Topics: Antimetabolites; Cycloserine; Double-Blind Method; Humans; Implosive Therapy; Panic Disorder; Smoking; Smoking Cessation

2016
Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.
    Psychopharmacology, 2012, Volume: 221, Issue:2

    Topics: Adult; Attention; Cues; Cycloserine; Double-Blind Method; Extinction, Psychological; Female; Follow-Up Studies; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Young Adult

2012
Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.
    Addictive behaviors, 2013, Volume: 38, Issue:2

    Topics: Adolescent; Adult; Analysis of Variance; Breath Tests; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cues; Cycloserine; Double-Blind Method; Extinction, Psychological; Female; Follow-Up Studies; Humans; Implosive Therapy; Intention to Treat Analysis; Male; Middle Aged; Placebos; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Self Report; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult

2013

Other Studies

1 other study(ies) available for cycloserine and Smoking Cessation

ArticleYear
D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 98, Issue:2

    Topics: Animals; Cycloserine; Female; Humans; Models, Animal; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Self Administration; Smoking; Smoking Cessation

2011